Ameritas Investment Partners’s Genomic Health, Inc. GHDX Stock Holding History

Ameritas Investment Partners’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,307	Closed	-$156K	–	3079
2019 Q3	$156K	Hold	2,307	–	–	0.01%	1200
2019 Q2	$134K	Buy	2,307 +573	+33%	+$33.9K	0.01%	1312
2019 Q1	$121K	Hold	1,734	–	–	0.01%	1360
2018 Q4	$112K	Hold	1,734	–	–	0.01%	1304
2018 Q3	$122K	Hold	1,734	–	–	0.01%	1422
2018 Q2	$87K	Hold	1,734	–	–	﹤0.01%	1627
2018 Q1	$54K	Hold	1,734	–	–	﹤0.01%	1885
2017 Q4	$59K	Hold	1,734	–	–	﹤0.01%	1845
2017 Q3	$54K	Hold	1,734	–	–	﹤0.01%	1857
2017 Q2	$56K	Buy	1,734 +289	+20%	+$9.15K	﹤0.01%	1841
2017 Q1	$46K	Buy	+1,445	New	+$42.7K	﹤0.01%	1911

Ameritas Investment Partners's GHDX Position: Q4 2019 in Review

Ameritas Investment Partners sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 2,307 shares — an estimated $156K sold.

Ameritas Investment Partners first reported a position in GHDX in Q1 2017 and held it in 11 quarters. The position peaked at $156K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Ameritas Investment Partners reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Ameritas Investment Partners sold 2,307 Genomic Health, Inc. shares in Q4 2019, an estimated $156K.
Ameritas Investment Partners first reported a position in Genomic Health, Inc. in Q1 2017 and held it in 11 quarters.
Ameritas Investment Partners's Genomic Health, Inc. position peaked at $156K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Ameritas Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.